Functional Outcomes & Scales

Standardized outcome measurement is fundamental to modern neurorehabilitation, serving as the common language for clinical trials, quality improvement, prognostication, and demonstration of treatment efficacy. The choice of outcome measure should be guided by the research question, the ICF domain of interest, the patient population, and practical considerations including sensitivity to change, floor/ceiling effects, and ease of administration. This topic provides a comprehensive overview of the most important outcome measures used in stroke rehabilitation and neurorehabilitation more broadly, along with frameworks for selecting the right tool for the right purpose.

Bottom Line

  • Modified Rankin Scale (mRS): The most commonly used primary endpoint in acute stroke trials; measures global disability on a 0–6 scale; a structured interview improves interrater reliability.
  • NIHSS: The standard for acute stroke severity assessment (0–42); biased toward left hemisphere and anterior circulation deficits; limited for posterior circulation stroke.
  • Functional Independence Measure (FIM): The most widely used measure in inpatient rehabilitation; 18 items scored 1–7; captures both motor and cognitive function.
  • Gait speed (10-meter walk test): A powerful, simple measure; <0.4 m/s = household ambulator, 0.4–0.8 m/s = limited community, >0.8 m/s = full community ambulator.
  • MoCA: The preferred cognitive screening tool for post-stroke cognitive impairment; more sensitive than MMSE for vascular cognitive impairment.
  • Minimal clinically important difference (MCID): The smallest change that matters to patients — critical for interpreting whether a statistically significant change is clinically meaningful.
  • ICF framework: Guides outcome selection by distinguishing body functions/structures, activity, and participation levels.

The ICF Framework

The World Health Organization’s International Classification of Functioning, Disability and Health (ICF) provides the conceptual framework for understanding and selecting outcome measures in rehabilitation.

ICF Level Definition Examples of Measures Clinical Relevance
Body Functions & Structures Impairments in physiological or psychological functions or anatomical structures NIHSS, Fugl-Meyer Assessment, Modified Ashworth Scale, MoCA, visual field testing Most specific to the neurological deficit; useful for understanding mechanisms and targeting treatment
Activity Ability to execute tasks or actions; limitations = “activity limitations” Barthel Index, FIM, 10-meter walk test, Action Research Arm Test, Box and Block Test Closest to what patients and caregivers experience daily; most commonly used in rehabilitation research
Participation Involvement in life situations; restrictions = “participation restrictions” Stroke Impact Scale, EQ-5D, return to work, community integration, social roles Hardest to measure; most meaningful to patients; influenced by environmental and personal factors beyond neurological impairment
Contextual Factors Environmental factors (physical, social, attitudinal) and personal factors (age, coping, motivation) Caregiver Burden Scale, social support measures, environmental assessment Powerful modifiers of outcome; often not formally measured but critical for understanding individual trajectories

Stroke-Specific Outcome Measures

NIHSS (National Institutes of Health Stroke Scale)

Item Domain Score Range
1a Level of consciousness 0–3
1b LOC questions (month, age) 0–2
1c LOC commands (open/close eyes, grip/release) 0–2
2 Best gaze (horizontal eye movements) 0–2
3 Visual fields 0–3
4 Facial palsy 0–3
5 Motor arm (L & R separately) 0–4 each
6 Motor leg (L & R separately) 0–4 each
7 Limb ataxia 0–2
8 Sensory 0–2
9 Best language (aphasia) 0–3
10 Dysarthria 0–2
11 Extinction and inattention (neglect) 0–2

NIHSS Key Points

  • Total score range: 0–42 (higher = more severe)
  • Severity categories: 0–4 minor, 5–15 moderate, 16–20 moderate-severe, 21–42 severe
  • Strengths: Standardized, widely used, strong interrater reliability with certification training, predicts outcome
  • Limitations:
    • Left hemisphere bias: Language items (aphasia 0–3, dysarthria 0–2) add more points for left hemisphere strokes; a right hemisphere stroke with severe neglect and anosognosia may score deceptively low
    • Anterior circulation bias: Poor capture of posterior circulation deficits (vertigo, diplopia, dysphagia, coordination); a devastating basilar artery occlusion may score only 2–4 on NIHSS
    • No cognitive assessment beyond language and neglect
  • Clinical use: Acute decision-making (thrombolysis/thrombectomy eligibility), monitoring during acute phase, prognostication

Modified Rankin Scale (mRS)

Score Description Functional Status
0 No symptoms Complete recovery
1 No significant disability despite symptoms Able to carry out all usual duties and activities; minor symptoms (e.g., subtle aphasia, mild weakness)
2 Slight disability Unable to carry out all previous activities but able to look after own affairs without assistance
3 Moderate disability Requires some help but able to walk without assistance
4 Moderately severe disability Unable to walk without assistance; unable to attend to own bodily needs without assistance
5 Severe disability Bedridden, incontinent, requires constant nursing care and attention
6 Dead —

mRS Key Points

  • Most commonly used primary endpoint in acute stroke trials (e.g., thrombolysis trials, thrombectomy trials)
  • Key trial cutoffs: mRS 0–1 = excellent outcome; mRS 0–2 = good outcome (most commonly used dichotomous endpoint in trials); mRS 3 = moderate disability (independent with aids)
  • Shift analysis: Modern trials increasingly use ordinal shift analysis (comparing entire mRS distribution) rather than dichotomized outcomes, as this provides greater statistical power
  • Structured interview (mRS-SI): Wilson et al. developed a structured interview that significantly improves interrater reliability compared to unstructured assessment; now recommended for all clinical trials
  • Limitations: Broad categories lack sensitivity to change within categories; subjective weighting of disability domains; less useful in rehabilitation (too insensitive to detect incremental gains)

Barthel Index (BI)

Item Max Score Description
Feeding 10 0 = unable, 5 = needs help (cutting, spreading), 10 = independent
Bathing 5 0 = dependent, 5 = independent
Grooming 5 0 = needs help, 5 = independent (face, hair, teeth, shaving)
Dressing 10 0 = dependent, 5 = needs help, 10 = independent
Bowels 10 0 = incontinent, 5 = occasional accident, 10 = continent
Bladder 10 0 = incontinent, 5 = occasional accident, 10 = continent
Toilet use 10 0 = dependent, 5 = needs some help, 10 = independent
Transfers (bed to chair) 15 0 = unable, 5 = major help, 10 = minor help, 15 = independent
Mobility (level surfaces) 15 0 = immobile, 5 = wheelchair independent, 10 = walks with help, 15 = independent
Stairs 10 0 = unable, 5 = needs help, 10 = independent
  • Total score: 0–100 (higher = more independent)
  • Strengths: Simple, widely used, well-validated, good reliability
  • Limitations: Ceiling effect in mild strokes (patients may score 100 but still have significant disability in instrumental ADLs); ordinal, not interval data; does not capture cognitive function

Functional Independence Measure (FIM)

FIM Overview

  • Structure: 18 items, each scored 1 (total assistance) to 7 (complete independence); total score 18–126
  • Motor subscale (13 items): Self-care (eating, grooming, bathing, dressing upper/lower, toileting), sphincter control (bladder, bowel), transfers (bed/chair, toilet, tub/shower), locomotion (walk/wheelchair, stairs)
  • Cognitive subscale (5 items): Comprehension, expression, social interaction, problem solving, memory
  • Scoring: 7 = complete independence; 6 = modified independence (extra time, device); 5 = supervision; 4 = minimal assist (patient ≥75%); 3 = moderate assist (patient ≥50%); 2 = maximal assist (patient ≥25%); 1 = total assist (patient <25%)
  • Most used outcome measure in inpatient rehabilitation in the US; required for IRF-PAI (Inpatient Rehabilitation Facility – Patient Assessment Instrument)
  • FIM gain: Discharge FIM − admission FIM; FIM efficiency = FIM gain / length of stay; used as a quality benchmark in rehabilitation facilities
  • Limitations: Copyright-protected (requires licensing); ceiling and floor effects; cognitive subscale limited; does not capture community participation

Upper Limb Outcome Measures

Measure Items/Score Time What It Measures Strengths/Limitations
Fugl-Meyer Assessment – Upper Extremity (FMA-UE) 33 items; 0–66 30–40 min Impairment-level motor function through Brunnstrom stages; voluntary movement, coordination, reflex activity, speed Gold standard for UE motor impairment; detailed; research standard; time-consuming; floor effect in severe patients
Action Research Arm Test (ARAT) 19 items; 0–57 10–15 min Activity level: grasp, grip, pinch, gross movement; uses standardized objects Good responsiveness; widely used in clinical trials; hierarchical structure allows abbreviated testing
Wolf Motor Function Test (WMFT) 17 items (time + quality) 30 min Timed performance of functional tasks from simple (forearm to table) to complex (lift basket) Primary outcome in EXCITE trial (CIMT); captures both ability and quality/speed; time-consuming
Box and Block Test Blocks moved in 60 seconds 2–5 min Gross manual dexterity; unilateral gross grasp and release Simple, quick, reliable; limited to single aspect of hand function
9-Hole Peg Test Time to complete (seconds) 2–5 min Fine manual dexterity; precision grasp and placement Quick, widely used (also in MS research); floor effect — many stroke patients unable to attempt

Gait and Mobility Measures

Measure Administration What It Measures Key Thresholds/Notes
10-Meter Walk Test (10MWT) Walk 10 meters; time the middle 6 meters (to exclude acceleration/deceleration); calculate speed (m/s) Gait speed — comfortable and fast speeds <0.4 m/s: household ambulator
0.4–0.8 m/s: limited community ambulator
>0.8 m/s: full community ambulator
MCID ≈ 0.16 m/s; simple, powerful predictor of function and health status
6-Minute Walk Test (6MWT) Walk as far as possible in 6 minutes on a measured course Walking endurance; cardiovascular fitness MCID ≈ 50 meters; correlates with community ambulation; distance reflects real-world walking capacity
Timed Up and Go (TUG) Rise from chair, walk 3 meters, turn, return, sit down; time in seconds Functional mobility, balance, fall risk >14 seconds associated with increased fall risk; quick bedside screen; limited sensitivity in higher-functioning patients
Berg Balance Scale (BBS) 14 items scored 0–4; total 0–56 Static and dynamic balance during functional tasks <45 associated with increased fall risk; ceiling effect in mild patients; widely used in rehabilitation
Functional Ambulation Categories (FAC) 6-point scale (0–5) Level of human assistance needed for ambulation 0 = non-ambulatory; 5 = independent everywhere including stairs; simple; useful for broad classification

Gait Speed as a “Vital Sign”

  • Gait speed has been proposed as the “sixth vital sign” due to its powerful predictive value for hospitalization, falls, functional decline, and mortality
  • The 10-meter walk test is one of the simplest and most informative measures available; it should be routinely assessed in all ambulatory stroke survivors
  • The community ambulation threshold categories (<0.4, 0.4–0.8, >0.8 m/s) provide immediately actionable clinical information about a patient’s functional mobility level

Cognitive Outcome Measures

Measure Score Range Time Best Use
MoCA (Montreal Cognitive Assessment) 0–30 (≤25 abnormal) 10 min Preferred screen for post-stroke and vascular cognitive impairment; assesses visuospatial, executive, attention, language, memory, orientation
MMSE (Mini-Mental State Examination) 0–30 (≤24 abnormal) 7–10 min General cognitive screen; less sensitive than MoCA for vascular/executive deficits; better for Alzheimer screening
Vascular Cognitive Impairment Battery Variable by component 30–60 min Standardized battery targeting vascular-pattern deficits (executive function, processing speed); recommended by NINDS-CSN harmonization standards

Patient-Reported Outcome Measures (PROs)

Measure Domain Description Strengths
Stroke Impact Scale (SIS) Multidimensional (8 domains) 59 items across strength, hand function, ADL/IADL, mobility, communication, emotion, memory/thinking, participation; plus stroke recovery rating (0–100 VAS) Comprehensive patient perspective; captures participation; sensitive to change across severity range; recommended for stroke rehabilitation research
EQ-5D Health-related quality of life 5 dimensions (mobility, self-care, usual activities, pain/discomfort, anxiety/depression) + VAS (0–100); utility index for cost-effectiveness analysis Brief; widely used in health economics; allows comparison across conditions; available in multiple languages
PHQ-9 (Patient Health Questionnaire-9) Depression 9 items mapping to DSM criteria for major depression; scored 0–27 Validated for post-stroke depression screening; cutoff ≥10 suggests major depression; quick and widely available
PROMIS measures Various (physical function, fatigue, pain, social participation, etc.) Item bank-based; computer adaptive testing or short forms; T-score metric (mean 50, SD 10) Modern psychometrics (IRT-based); flexible administration; allows cross-condition comparison; increasingly used in rehabilitation research

Prognostic Models

Model Components Predicts Key Feature
ASTRAL Score Age, severity (NIHSS), time to admission, range of visual fields, acute glucose, level of consciousness 3-month functional outcome (mRS) Validated in large European cohort; simple bedside calculation
iScore Age, sex, stroke severity (Canadian Neurological Scale), stroke subtype, risk factors, pre-stroke disability, glucose, comorbidities 30-day and 1-year mortality and disability Comprehensive; available as online calculator
PLAN Score Preadmission comorbidities, level of consciousness, age, neurological deficit 30-day mortality, 1-year mortality and disability Designed for simplicity; validated in multiple cohorts
PREP2 Algorithm SAFE score (shoulder abduction + finger extension), TMS, age, NIHSS Upper limb motor recovery category at 3 months Most validated biomarker-based prediction tool for motor recovery (see Motor Recovery topic)

Minimal Clinically Important Difference (MCID)

The MCID represents the smallest change in an outcome measure that patients perceive as beneficial and that would justify a change in clinical management. It is essential for determining whether a statistically significant result in a trial is clinically meaningful.

Outcome Measure MCID Context/Notes
Modified Rankin Scale (mRS) 1 point Represents a meaningful change in global disability level; shift analysis considers the entire distribution
NIHSS 2–4 points Varies by baseline severity; larger change needed to be meaningful at higher baseline scores
10-Meter Walk Test 0.16 m/s Crossing a community ambulation threshold (e.g., from <0.4 to >0.4 m/s) is especially meaningful
6-Minute Walk Test 50 meters Approximately 20% improvement from typical post-stroke baseline
Fugl-Meyer Assessment – UE 5–10 points 5 points for early phase; 10 points for chronic phase (when spontaneous recovery is minimal, larger changes are needed to be perceived as meaningful)
Action Research Arm Test (ARAT) 5.7–12 points Varies by study and baseline severity
Barthel Index ~10 points Corresponds to becoming independent in 1–2 ADL items
Functional Independence Measure (FIM) 22 points (total FIM); 17 points (motor subscale) Total FIM; domain-specific MCIDs also established
Berg Balance Scale 3–7 points Crossing below 45 (fall risk threshold) is especially clinically relevant
Timed Up and Go 2.9 seconds Especially meaningful when crossing the 14-second fall risk threshold

Quality Metrics in Stroke Care

Beyond individual patient outcomes, system-level quality metrics are essential for benchmarking stroke care quality and driving improvement.

Quality Metric Target Rationale
Door-to-needle time (IV tPA) ≤60 minutes Every 15-minute delay in tPA reduces favorable outcomes; AHA/ASA target ≤60 minutes from ED arrival
Door-to-puncture time (thrombectomy) ≤90 minutes Faster reperfusion improves outcomes; systems of care optimization critical
Stroke unit care All stroke patients Organized stroke unit care reduces mortality and disability (Stroke Unit Trialists meta-analysis); NNT ~20 to prevent one death or dependency
Dysphagia screening Before any oral intake Reduces aspiration pneumonia; bedside swallow screen or formal assessment
DVT prophylaxis All immobilized patients Pharmacologic (LMWH/heparin) or mechanical (IPC) prophylaxis; CLOTS-3 supports IPC when pharmacologic contraindicated
Early mobilization 24–48 hours AVERT trial: early mobilization beneficial but not within first 24 hours and not at very high intensity
Discharge planning Begin at admission Multidisciplinary team assessment; rehabilitation needs assessment; caregiver education; outpatient follow-up planning
Secondary prevention Before discharge Antiplatelet/anticoagulation, statin, antihypertensive, diabetes management, smoking cessation, lifestyle counseling

Choosing the Right Outcome Measure

Practical Guide to Outcome Selection

  • Match to ICF level: Is the question about impairment (use FMA, NIHSS, MAS), activity (use FIM, Barthel, gait speed), or participation (use SIS, EQ-5D)?
  • Match to patient population: Avoid measures with floor effects in severe patients (ARAT in patients with no hand movement) or ceiling effects in mild patients (Barthel Index in mRS 0–1 patients)
  • Consider responsiveness: The measure must be sensitive enough to detect the expected change over the study period; FMA-UE is more responsive than ARAT for detecting early motor recovery
  • Practical considerations: Training requirements, time to administer, copyright/licensing costs, availability of normative data
  • Use multiple levels: A comprehensive assessment battery should include measures at impairment, activity, and participation levels to capture the full impact of the neurological condition and the rehabilitation intervention
  • Include patient-reported outcomes: What patients perceive and value may differ from what clinicians measure; PROs capture the patient perspective and are increasingly required in clinical trial design

References

  1. Brott T, Adams HP Jr, Olinger CP, et al. Measurements of acute cerebral infarction: a clinical examination scale. Stroke. 1989;20(7):864–870.
  2. van Swieten JC, Koudstaal PJ, Visser MC, et al. Interobserver agreement for the assessment of handicap in stroke patients. Stroke. 1988;19(5):604–607.
  3. Wilson JT, Hareendran A, Grant M, et al. Improving the assessment of outcomes in stroke: use of a structured interview to assign grades on the modified Rankin Scale. Stroke. 2002;33(9):2243–2246.
  4. Mahoney FI, Barthel DW. Functional evaluation: the Barthel Index. Md State Med J. 1965;14:61–65.
  5. Keith RA, Granger CV, Hamilton BB, Sherwin FS. The functional independence measure: a new tool for rehabilitation. Adv Clin Rehabil. 1987;1:6–18.
  6. Fugl-Meyer AR, Jaasko L, Leyman I, et al. The post-stroke hemiplegic patient. 1. A method for evaluation of physical performance. Scand J Rehabil Med. 1975;7(1):13–31.
  7. Perry J, Garrett M, Gronley JK, Mulroy SJ. Classification of walking handicap in the stroke population. Stroke. 1995;26(6):982–989.
  8. Nasreddine ZS, Phillips NA, Bédirian V, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53(4):695–699.
  9. Duncan PW, Wallace D, Lai SM, et al. The Stroke Impact Scale version 2.0: evaluation of reliability, validity, and sensitivity to change. Stroke. 1999;30(10):2131–2140.
  10. Tilson JK, Sullivan KJ, Cen SY, et al. Meaningful gait speed improvement during the first 60 days poststroke: minimal clinically important difference. Phys Ther. 2010;90(2):196–208.
  11. Page SJ, Fulk GD, Boyne P. Clinically important differences for the upper-extremity Fugl-Meyer Scale in people with minimal to moderate impairment due to chronic stroke. Phys Ther. 2012;92(6):791–798.
  12. World Health Organization. International Classification of Functioning, Disability and Health (ICF). Geneva: WHO; 2001.
  13. Stroke Unit Trialists’ Collaboration. Organised inpatient (stroke unit) care for stroke. Cochrane Database Syst Rev. 2013;(9):CD000197.
  14. Hsueh IP, Lin JH, Jeng JS, Hsieh CL. Comparison of the psychometric characteristics of the functional independence measure, 5 item Barthel index, and 10 item Barthel index in patients with stroke. J Neurol Neurosurg Psychiatry. 2002;73(2):188–190.